Bank Of America Corp Apellis Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.19 Trillion
- Q3 2024
A detailed history of Bank Of America Corp transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 975,004 shares of APLS stock, worth $32.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
975,004
Previous 995,069
2.02%
Holding current value
$32.6 Million
Previous $38.2 Million
26.33%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$521 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$398 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$372 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$328 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$194 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.68B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...